Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
just went through
Just put another test buy on the ask too see how long to fill, been a couple of minutes already
a lot of shares traded hands in this range yesterday, can't imagine too many sellers
I just put a very small test buy through at .009 to see how fast it would fill, it did and took just a few minutes.
I wonder how many shares were traded on the dip down yesterday. The MM's did not get all those shares, a lot of Ihubbers picked up some. Interesting also, when the trading stands still a nice jump has usually followed, as if they were holding trades on the shake.
There cant be many shares to be sold at these levels
This might be as good a shake as the MM's have. All the .01 profit takers did their business yesterday. Should be a nice rise this morning-IMO
short interest has gone way down, not that it was alot to begin with.
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=cirt
I noticed that thebullpick.com has taken down eeso from their front page and just says stay tuned. I also noticed that the day after thebullpick.com issued eeso pick 3/26 the next day volume went bonkers and a string of PR ensued.
according to this page
http://thebullpick.com/compensation.htm
CIRT has given them 500,000 shares for two weeks of promotional service. Their "normal" fee seems to be $10g's. This equates to .02 a share.
<Speculation>
Hopefully they are getting ready to put CIRT on their front page and a bunch of great PR's will follow.
If we get any kind of PR this thing will blow up!!!!!!!
I love it when the bid is higher than the last sale.
Good point
I believe he wanted to see consolidation going on above the .008 support level to continue as volume declines. That this would set up the explosive combination by building strength.
Claytraders video chart made the comment that the BEST case scenariofor consolidation would be if the .008 support level held, and it seems to be doing just that. A little consolidation and them BOOM!
http://www.tradewithoutemotion.com/claytrader_s_video_blog
Wish I had some funds, I would be buying right here!
Doesn't it have to generate a consireable income for the insurance to be written to cover BLCOC loan??
New Alert
StandoutStocks.com: StandoutStocks.com "Stocks that Standout" today are -- -- BCST, CIRT, ILNS, PTSC, TOOT, TSSW
Apr 10, 2008 (M2 PRESSWIRE via COMTEX) -- StandoutStocks.com "Stocks that Standout" today are: Broadcast International (OTCBB: BCST), Cardio Infrared Technologies, Inc. (PINKSHEETS: CIRT), Intellect Neurosciences, Inc. (OTCBB: ILNS), Patriot Scientific (OTCBB: PTSC), The Tootie Pie Company, Inc. (OTCBB: TOOT) and TouchStone Software Corporation (OTCBB: TSSW)
Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at http://www.Standoutstocks.com Apr 10, 2008 -- Broadcast International (OTCBB: BCST) ("BI") today announced it will demonstrate live HD video encoding under 3 Mbps at the National Association of Broadcasters (NAB) conference in Las Vegas next week. The demonstration at the Broadcast International booth (# SU 14310) marks the first time in the broadcast industry video will be encoded from a live camera feed at this rate of video compression.
Until now, most HD video has been transmitted at the MPEG 2 standard of 19.4 Mbps. By compressing video to under 3Mbps, Broadcast International enables video providers to reduce their bandwidth needs by more than 80 percent for HD quality and pack more video into less bandwidth. Conservation of limited bandwidth resources has become a critical requirement in the broadcast, cable, satellite, mobile and IPTV markets, especially as bandwidth-intensive, high-definition video becomes the industry standard.
"The ability to squeeze more video onto less bandwidth is the number one priority in the industry," said Rod Tiede, CEO of Broadcast International. "Even a 20 percent reduction in bandwidth is seen as a breakthrough. Our demonstrations shatter the bandwidth barrier completely, offering unprecedented compression and transcoding in both live and real-time environments. That's the industry's holy grail."
Broadcast International will also demonstrate real-time video encoding and transcoding, translating video from one format to another, in IBM booth # SU 3614 where its CodecSys video compression software will be integrated with the IBM Media Hub Solution Framework, IBM's services oriented architecture (SOA)-based solution for the media and entertainment industry that is designed to manage the increasing complexity of running a content-focused business from the point of creation to the distribution of digital content. In this demonstration, which emulates a production broadcast environment, a variety of content, from live sportscasts to archived footage, will be encoded and transcoded in real-time for delivery over multiple modes of distribution to cellphones, laptops, and large-screen format HDTVs.
The real-time transcoding is necessary to deal with the complexity caused by the scores of file formats, bit rates, screen resolutions, and audio and video codecs involved in the video distribution process. A single piece of video, for example, may need to be transcoded dozens of times for the mobile and Internet distribution channels alone. Capabilities such as real-time transcoding are critical if video content is to become ubiquitous across all media delivery platforms.
IBM's Cell multi-core processor accelerates video compression and transcoding
The NAB demonstrations utilize Broadcast International's patented CodecSys video compression software running on the IBM BladeCenter(R) QS21 server. In December 2007, Broadcast International announced a license agreement with IBM. The agreement covers Broadcast International's CodecSys video compression software running on the Cell Broadband Engine(TM) (Cell/B.E.) multi-core processor and the IBM BladeCenter(R) QS21 server. The combined technologies promise to change the video distribution world by making it possible for cable, satellite or IPTV providers to deliver live HDTV at compression levels four to six times higher than is currently possible.
"We are constantly striving to provide innovative solutions to our customers," said Jim Comfort, vice president, IBM Systems and Technology Group. "The IBM BladeCenter QS21, based on the multi-core Cell Broadband Engine processor, is designed to yield quicker application results, enabling organizations to get information faster in order to facilitate important business decisions. In combination with Broadcast International's CodecSys software, this game-changing technology solution will have a profound impact on the video distribution industry."
"This combination of the incredibly powerful Cell Broadband Engine, IBM BladeCenter QS21 and BI's completely new approach to encoding, using multiple expert encoders in parallel, will change the entire economics of the video industry overnight," said Peter White, CEO of Rethink Research Associates in the U.K., and contributing analyst for Multimedia Research Group.
Unmatched video compression
CodecSys utilizes a patented, multi-codec approach in which a video stream is analyzed and the codec best-suited for a particular frame or video sequence is automatically selected from an entire library of specialized codecs.
These specialist codecs are designed to handle particular types of high-bandwidth video frames or streams, such as fast-motion sequences in a basketball game or explosions in an action movie. These types of video are extremely bandwidth-intensive and pose chokepoints to generalist codecs. By selecting the best expert codec for the job, CodecSys is able to eliminate these chokepoints and offer performance several times higher than competitive products based on general-purpose codecs.
The Cell/B.E. processor accelerates the CodecSys compression and codec-switching process, providing a platform for nearly unlimited processing power and video compression capabilities. The combined technologies deliver live HDTV at compression levels four to six times higher than is currently possible.
A "future-proof" solution
One of the key benefits of the CodecSys software approach is CodecSys-based encoders can be easily changed as standards and requirements evolve. With CodecSys, codecs can be upgraded and added through simple, cost-effective software downloads. Other commercial solutions based on embedded systems require costly, full replacement. The underlying IBM multi-core hardware platform is also highly programmable and scalable, enabling users to add additional processing power by simply adding extra processors.
This upgradeable, "future-proof" approach eliminates the need for the costly replacement cycles required with encoders based on tightly-coupled hardware/software architectures.
"Right now," said Tiede, "there are literally billions of dollars in video compression infrastructure that will have to be thrown away when new standards like h.264 are adopted. You don't have to throw out your computer every time Microsoft launches a new version of software. Why should you have to throw away a $50,000 piece of equipment like an encoder? It just doesn't make sense."
About Broadcast International
Broadcast International is a leading provider of video-powered broadcast solutions, including IP, and digital satellite, Internet streaming and other types of wired/wireless network distribution. BI's patented CodecSys software is a breakthrough, artificial intelligence-based video compression technology that cuts video bandwidth requirements more than 80% over satellite, cable, IP and wireless networks. By slashing bandwidth needs, CodecSys enables a new generation of applications such as streaming video to cell phones, and offers unprecedented price/ performance benefits for existing applications such as HD video.
Broadcast International is a public company (OTCBB: BCST) headquartered in Salt Lake City, UT.
Apr 8, 2008 -- Cardio Infrared Technologies, Inc. (PINKSHEETS: CIRT), a leading Health and Wellness technology and marketing company, announced today those shipments of the Cardio-Cor units that were sold during and after the Anti-Aging Show in Las Vegas, Nevada in December 2007 began shipping the week of March 3, 2008.
Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc., stated, "Sales of the Cardio-Cor are requiring an unusually long sales process; more than Cardio's normal sales within our target market. Purchasers existing facilities are already cramped for space from existing treatment and procedure equipment. If an existing facility wants to purchase a Cardio-Cor Exerbike they must often remove and relocate existing equipment or treatment areas and add to or expand their current facility. This process usually requires reallocation of resources to expand and or locate a new lease and often move to a new location. Cardio Infrared Technologies, Inc. is working with a number of clients that are in this process and will be ready for units to be delivered soon.
Cardio Infrared Technologies, Inc. has a significant back log of customers in various stages of moving, building, expanding or awaiting to complete start-up facilities so that they can complete their purchase and take delivery of the Cardio-Cor units.
About Cardio Infrared Technologies, Inc.
Cardio Infrared Technologies, Inc is a technology and marketing company, which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market to every country around the world. The equipment has already been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes acquisitions and development of innovate new equipment in the exercise and medical industries.
April 10, 2008 -- Intellect Neurosciences, Inc. (OTCBB: ILNS), announced today that it has obtained a Notice of Allowance and completed the grant requirements to obtain a European patent relating to the Company's ANTISENILIN(R) antibodies and products being developed by the Company for the treatment of Alzheimer's disease. Grant of the European patent is expected in several weeks. Other patents related to the ANTISENILIN(R) antibodies have been granted in Japan, China and elsewhere. Patent applications are pending in the United States. Intellect Neurosciences is the exclusive assignee of the ANTISENILIN(R) patents, which are based on the invention of Dr. Daniel Chain, the Company's Chairman and CEO.
Dr. Chain commented: "The use of ANTISENILIN(R) monoclonal antibodies that specifically target the toxic forms of beta amyloid is at the forefront of the battle against Alzheimer's disease. In addition to the Company's products in development, our invention has been applied to promising drug candidates in clinical development by major pharmaceutical companies."
"Intellect's ANTISENILIN(R) antibody technology incorporates an important safety feature ("free-end specificity"), meaning that antibodies developed using the technology are designed to specifically block the neurotoxicity of beta amyloid, which accumulates in the brains of Alzheimer's patients. The blocking of the neurotoxicity is achieved by promoting clearance of beta amyloid away from sites of damage while minimizing the potential for adverse effects," explained Professor Donald Price, Professor of Pathology, Neurology and Neuroscience and Founding Director of the Alzheimer's Disease Research Center at The Johns Hopkins School of Medicine and a member of Intellect's Scientific Advisory Board. Professor Price added: "Dr. Chain's idea of using antibodies in this way to reduce amyloid toxicity in the brain has gained considerable momentum over the past few years and we are currently optimistic that drugs of this type herald an exciting new era of drug development for safe and efficacious disease-modifying treatments for this devastating disease."
About Intellect's Immunotherapy Platforms for Alzheimer's disease
Immunotherapy for Alzheimer's disease involves making an antibody molecule available to bind to the endogenous beta-amyloid toxin, thus promoting its clearance away from the brain. This therapeutic outcome can be achieved either by provoking the patient's immune system to generate such an antibody (active immunization) or by administering an externally generated antibody (passive immunization). Both approaches have the potential to slow or arrest disease progression provided that key safety issues are addressed. Intellect has incorporated proprietary safety features into its ANTISENILIN(R) and RECALL-VAX(TM) technology platforms for both passive and active immunization, respectively. These features and supporting patent position provides the Company with a strong competitive advantage in this field.
About Alzheimer's disease
Alzheimer's disease, the most common form of dementia, is characterized by progressive loss of memory and cognition, ultimately leading to complete debilitation and death. A hallmark feature of Alzheimer's pathology is the presence of insoluble protein deposits known as beta-amyloid on the surface of nerve cells, which results from the accumulation of soluble beta-amyloid in the brain. The effects of the disease are devastating to the patients as well as the caregivers, with significant associated health care costs. It is estimated that there are over 12 million people suffering from Alzheimer's disease in the in the developed countries with the number increasing also in developing countries as the global population ages. Currently marketed drugs transiently affect some of the symptoms of the disease, but there are no drugs on the market today that slow or arrest the progression of the disease. These symptomatic drugs are projected to generate approximately $4 billion in sales by 2008, indicating both the size of the market and the demand for effective treatment beyond symptomatic improvements.
About Intellect Neurosciences, Inc.
Intellect Neurosciences, Inc. is a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other disorders. The company has a broad proprietary immunotherapy platform for both passive and active immunization against Alzheimer's disease. Also, Intellect has recently completed Phase I clinical trials for OXIGON(TM), a unique antioxidant and anti-amyloid compound that has potential to treat Alzheimer's disease and other disorders.
Apr 09, 2008 -- Patriot Scientific (OTCBB: PTSC) announced today operating results for the third fiscal quarter ended February 29, 2008.
Patriot Scientific reported Q3 FY'08 pre-tax income of $10.7 million, an increase of 9% over Q3 FY'07. The company's operating results include $11.7 million in equity earnings from Phoenix Digital Solutions, the joint venture entity owned half by Patriot Scientific and half by The TPL Group. Net income for Q3 FY'08 was $6.3 million, with basic and diluted earnings per share of $0.02. On February 29, Patriot had $25.6 million in current assets, inclusive of $23.2 million in cash and short-term investments. Current liabilities of $4.6 million included $4.0 million in income taxes payable that will be remitted prior to the end of the fourth fiscal quarter.
For the nine months ended February 29, 2008, the company received cash distributions from Phoenix Digital totaling $16.7 million. Phoenix Digital receives its income from licenses purchased by manufacturers who use technologies protected by the MMP(TM) Portfolio. From these cash flows $5.8 million was invested by Patriot in the repurchase of outstanding shares and warrants, while significant tax liabilities of $9.2 million were paid.
Revenues for Phoenix Digital from technology license agreements for the three and nine-month periods ended February 29, 2008 were $27.9 million and $48.9 million, respectively. Net income for Phoenix Digital increased by 8%, compared to Q3 FY'07, to $25.2 million. As stated in previous company announcements, the dollar amount for each licensing deal varies depending upon factors that include, among other things, the relevance of the patents to each licensee's product revenues and the extent to which the patented technology is incorporated into specific products. Currently more than 40 major electronic companies have signed licenses for the MMP Portfolio.
"Patriot's strong cash position and public market listing will become the foundation for investing in other businesses," said recently appointed Patriot Scientific CEO Rick Goerner. "We are aggressively seeking to put the company's capital to work in the acquisition of new IP technologies and operating businesses that we believe will provide a platform for incremental, sustainable and predictable future growth."
Goerner confirmed the company's commitment, and priority, to create increased shareholder value by expanding the business through strategic acquisitions in key technology segments.
"We have been fortunate to benefit from strong past cash flows and it is now time for the company to focus on finding alternative uses for our cash and stock. Many growth companies, and their technologies, could benefit from Patriot's cash and network resources and its access to the public market. We believe this is a particularly good time to capitalize on these opportunities. The recent addition of Paul Bibeau as Patriot's vice-president of business development expands our capability to support the evaluation effort of these opportunities. Paul's background and experience is proving invaluable in allowing us to efficiently sort through and evaluate potential acquisition candidates."
Goerner added, "I know many current, and prospective, shareholders desire more information about Patriot's business and future plans. We will provide a supplemental news release with additional details about our business plans and the direction we are moving, as well as answer questions we see commonly posed to us by the investor community."
About Patriot Scientific
Patriot Scientific is a leading intellectual-property licensing company that develops, markets, and enables innovative technologies that satisfy the demands of fast-growing markets for wireless devices, smart cards, home appliances, network gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices, industrial controllers and more. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.patriotscientific.com.
An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/profile/ptsc.cfm. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. To receive free e-mail notification of future releases for Patriot Scientific, sign up at http://www.hawkassociates.com/about/alert/.
About the MMP Portfolio
The Moore Microprocessor Patent (MMP) Portfolio contains intellectual property that is jointly owned by the publicly held Patriot Scientific Corporation (OTCBB:PTSC) and privately held The TPL Group. The portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is becoming widely recognized that these patents protect fundamental technology used in designing microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. The MMP portfolio is exclusively managed by Alliacense, the licensing arm of The TPL Group.
Apr 09, 2008 -- The Tootie Pie Company, Inc. (OTCBB: TOOT), a premium baker and seller of high-quality, handmade pies, announced today that it sold in excess of 8,000 pies for the quarter ending March, 2008; an increase of approximately 100% over the 4,000 plus pies sold during the same quarter in 2007.
"The majority of our sales for this quarter came from our primary wholesale distributors in existing markets and thus represent growth in 'same store sales.' As we enter new markets, with another 'food show season' in full swing, we are already seeing similar positive results from customers in these markets as well," said Don Merrill, Tootie Pie Company's President & CEO.
Tootie Pie Company bakes and sells high-quality, handmade pies through three basic sales channels: retail, corporate and wholesale. The retail segment serves individual consumers through in-store sales, orders via telephone and internet on the Company's website. The corporate segment serves businesses that purchase pies as a way to promote their company through client and employee appreciation programs. The wholesale segment is made up of regional and national broad-line foodservice distributors who purchase pies and then resell them to their customers.
Apr 10, 2008 -- TouchStone Software Corporation (OTCBB: TSSW), a leading provider of PC Optimization Tools, today announced that it has signed a definitive agreement to be acquired by Phoenix Technologies Ltd., (Nasdaq: PTEC), the global leader in core systems software. Under the terms of the agreement, TouchStone stockholders will receive $1.48 in cash for each share of TouchStone common stock, representing a 29% premium over the closing price of TouchStone's stock on April 9, 2008.
The proposed transaction has been unanimously approved by TouchStone's board of directors. The transaction is expected to be completed within 90 days, subject to various conditions, including approval by TouchStone's stockholders and other customary closing conditions. A special meeting of TouchStone's stockholders will be scheduled as soon as practicable following the preparation and filing of proxy materials with the Securities and Exchange Commission.
"By joining the Phoenix organization, we believe that TouchStone will benefit from the leverage offered by a larger parent similarly focused on technology innovation," said Jason Raza, President and CEO of TouchStone. "This acquisition is expected to enable TouchStone's products to be exposed to a much broader customer base and exposure to Phoenix's vast OEM base. The board of directors believes this transaction is in the best interest of our stockholders."
"TouchStone is a sterling addition to Phoenix's product and service portfolio enabling our PC 3.0(TM) vision," said Woody Hobbs, President and CEO of Phoenix Technologies. "We are delighted with this acquisition and welcome the TouchStone team to Phoenix Technologies. The combination of our core BIOS products and firmware-based applications and the TouchStone team will enable Phoenix to deliver the most complete offering for the deployment and management of PC-related products and services in the PC industry."
IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE SEC
TouchStone plans to file with the SEC and mail to its stockholders a Proxy Statement in connection with the transaction. The Proxy Statement will contain important information about TouchStone, the transaction and related matters. Investors and security holders are urged to read the Proxy Statement carefully when it is available.
Investors and security holders will be able to obtain free copies of the Proxy Statement and other documents filed with the SEC by TouchStone through the web site maintained by the SEC at www.sec.gov. In addition, investors and security holders will be able to obtain free copies of the Proxy Statement from TouchStone by contacting Investor Relations, TouchStone Software Corporation, 1538 Turnpike Street, North Andover, MA 01845, 978-686-6468.
TouchStone and its directors and executive officers, may be deemed to be participants in the solicitation of proxies with respect to the transactions contemplated by the merger agreement. Information regarding TouchStone's directors and executive officers is contained in TouchStone's Annual Report on Form 10-K for the year ended December 31, 2007, which is filed with the SEC. As of April 1, 2008, TouchStone's directors and executive officers beneficially owned approximately 4,143,048 million shares, or 34.2%, of TouchStone's common stock. Stockholders representing approximately 34.2% of the voting stock of TouchStone have signed a stockholder agreement agreeing to vote for the approval of the merger agreement and the transactions contemplated therein.
About Standoutstocks.com
Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.htm
CONTACT: Standoutstocks.com e-mail: info@standoutstocks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2008 M2 COMMUNICATIONS LTD
-0-
ALRIGHT PEEPS, LUNCHTIME IS OVER!!!!!
TIME TO TRADE!!!!!!!!!!!!
Yesterday it seemed to gain strength in the morn, and blew up in the afternoon. A lot of similarity here, things are shaping up.
Looks like the low dips are forming a trend line upward bouncing off of .012 on the top side. With volume this should blow in a little bit.
As Claytrader says, lifting weights here so babes can check us out on the beach later.
I like this, a little consolidation between .012 and .01...............followed by a big move above .015 on up
(William Shatner voice):....Gotta........get.........through....this............................Resistance.......aghhhhhhhhh
Yesterday, when the action seemed to have come to a stand still, it was followed by a big move up!!! I think we will see the same in a few minutes here
Fishy no catchy
agreed, volume is great, people buying here wont want to sell below that. Lot of shares trading hands compared to size of float.
Here's our little resistance zone. Chew this up and be outta here.
I agree, I had a sell order yesterday on 1/2 my small stack and cancelled before it got there. It is/was moving like a freight train. Still holding
With controlled selling, we might see .02 by lunch!
starting to feel like the end of the day yesterday. No selling, small buying moving it up!
Let's get back to the Motherland!
I think you hit it!! Good chance to get in, were going bye bye
Maybe some big volume right off the bat! I Love it!!!!!!!!!
Repost:
Posted by: ClayTrader
In reply to: None Date:4/9/2008 6:35:36 PM
Post #of 13650
.<font color=green> ** CIRT Video Chart - 4/9/2008 **
One word: WOW...
My thoughts in video format ---> http://www.tradewithoutemotion.com/claytrader_s_video_blog
There's got to be some GOLF in there somewhere!!!!
I think we are going to be smiling for a while!
IMO - with some buying pressure I think we blow past 3 in about 5 minutes and 4 in about 30 minutes
Very interesting Posts by esi23 today, sounds like the ceo is very busy and business is beginning to boom.
Posted by: esi23
In reply to: Cadillac13 who wrote msg# 901 Date:4/9/2008 12:04:07 PM
Post #of 1414
Just spoke to Wayne Bailey, very nice, sales are going through the roof and we will hear very soon. Dilution not a problem has complted 504 offering much higher than this price cannot reveal. There are levels that they can sell at.
-------------------------
Posted by: esi23
In reply to: ShowTuneLover who wrote msg# 1107 Date:4/9/2008 2:50:07 PM
Post #of 1414
I did speak to the CEO...he is trying to fill orders now. This could be the next tanning bed. He sells to healthcenters, chiropractors, tanning salons MDs the list goes on. He said now he is scrambling to fill orders from trade show. Private investors calling him lately, basically alot of interest. They have completed the 504, i asked if they would be selling here, and he said to the effect...why would they want to lose money down here. Very positive. He does have exclusive rights for the US.
Factory Tour Video,
Maybe this is old, but here it is:
http://www.premierguitar.com/Magazine/Issue/2008/Apr/Grem_USA_Factory_Tour.aspx